Apimeds Pharmaceuticals US, Inc.
APUS • AMEX • Stock Fundamentals
Apimeds Pharmaceuticals US, Inc. is a pharmaceutical preparations company trading on AMEX, led by CEO Vinod Menon, with a market cap of $37.7M.
Market Cap$37.7M
Employees2.0
CEOVinod Menon
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Most Recent EarningsMay 4, 2026 · 2 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricAPU
Apimeds Pharmaceuticals US, Inc. FAQ
Common questions about Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. (APUS) has a market capitalization of $37.7M and trades on AMEX.
Apimeds Pharmaceuticals US, Inc. has approximately 2 employees.